Trial Profile
A Randomized, Double-Blind, Single-Dose Study to Assess the Pharmacodynamic Effects of SM-1 Versus Comparator and Placebo in a 5 Hour Phase Advance Model of Insomnia in Adults Who Suffer From Short-Term Insomnia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Diphenhydramine/lorazepam/zolpidem (Primary) ; Lorazepam; Zolpidem
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Sequential Medicine Ltd
- 12 Sep 2016 Status changed from not yet recruiting to completed.
- 15 Feb 2016 New trial record